Muscle cell‐derived cytokines in skeletal muscle regeneration

RJ Waldemer‐Streyer, D Kim, J Chen - The FEBS journal, 2022 - Wiley Online Library
Regeneration of the mammalian adult skeletal muscle is a well‐orchestrated process
regulated by multiple proteins and signalling pathways. Cytokines constitute a major class of …

Neuroprotection through G-CSF: recent advances and future viewpoints

V Rahi, S Jamwal, P Kumar - Pharmacological Reports, 2021 - Springer
Granulocyte-colony stimulating factor (G-CSF), a member of the cytokine family of
hematopoietic growth factors, is 19.6 kDa glycoprotein which is responsible for the …

Golodirsen for Duchenne muscular dystrophy.

S Anwar, T Yokota - Drugs of Today (Barcelona, Spain: 1998), 2020 - europepmc.org
Duchenne muscular dystrophy (DMD) is a life-shortening X-linked genetic disorder
characterized by progressive wasting and weakening of muscles in boys. Loss-of-function …

Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset

V Mournetas, E Massouridès, JB Dupont… - Journal of cachexia …, 2021 - Wiley Online Library
Background Duchenne muscular dystrophy (DMD) causes severe disability of children and
death of young men, with an incidence of approximately 1/5000 male births. Symptoms …

Applying genome-wide CRISPR-Cas9 screens for therapeutic discovery in facioscapulohumeral muscular dystrophy

A Lek, Y Zhang, KG Woodman, S Huang… - Science translational …, 2020 - science.org
The emergence of CRISPR-Cas9 gene-editing technologies and genome-wide CRISPR-
Cas9 libraries enables efficient unbiased genetic screening that can accelerate the process …

Update on muscular dystrophies with focus on novel treatments and biomarkers

N Datta, PS Ghosh - Current neurology and neuroscience reports, 2020 - Springer
Abstract Purpose of Review Muscular dystrophies are a heterogeneous group of inherited
muscular disorders characterized by progressive muscle weakness and in many cases …

In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse

L Amoasii, H Li, Y Zhang, YL Min… - Nature …, 2019 - nature.com
Duchenne muscular dystrophy (DMD) is a fatal genetic disorder caused by mutations in the
dystrophin gene. To enable the non-invasive analysis of DMD gene correction strategies in …

TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy

D Xu, S Li, L Wang, J Jiang, L Zhao… - Journal of cachexia …, 2021 - Wiley Online Library
Background Transforming growth factor‐β‐activated kinase 1 (TAK1) plays a key role in
regulating fibroblast and myoblast proliferation and differentiation. However, the TAK1 …

A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy

GH Farr, M Morris, A Gomez, T Pham, E Kilroy… - Skeletal Muscle, 2020 - Springer
Background Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder and
is one of the most common muscular dystrophies. There are currently few effective therapies …

Polymeric nanoparticles functionalized with muscle-homing peptides for targeted delivery of phosphatase and tensin homolog inhibitor to skeletal muscle

D Huang, F Yue, J Qiu, M Deng, S Kuang - Acta biomaterialia, 2020 - Elsevier
Phosphatase and tensin homolog (PTEN) antagonizes muscle growth and repair, and
inhibition of PTEN has been shown to improve the pathophysiology and dystrophic muscle …